The Alzheimer's disease THErapy with NEuroaid (ATHENE) study protocol: Assessing the safety and efficacy of Neuroaid II (MLC901) in patients with mild-to-moderate Alzheimer's disease stable on cholinesterase inhibitors or memantine—A randomized, double-blind, placebo-controlled trial

BACKGROUND: Dementia is a large and growing health care burden globally, and its major cause is Alzheimer's disease (AD). MLC901 (Neuroaid II) is a simplified form of MLC601 (Neuroaid), a Traditional Chinese Medicine with neuroprotective and neuroproliferative properties in cellular and animal...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Christopher L.H., Sharma, Purabi Reang, Tan, Boon Yeow, Low, Casuarine, Venketasubramanian, Narayanaswamy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Featured Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352850/
https://www.ncbi.nlm.nih.gov/pubmed/30723778
http://dx.doi.org/10.1016/j.trci.2018.12.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352850/
https://www.ncbi.nlm.nih.gov/pubmed/30723778
http://dx.doi.org/10.1016/j.trci.2018.12.001

Ejemplares similares